ArticleInterdisciplinary sciences, computational life sciences2026
MKLNID: Identifying Melanoma-related Pathogenic Genes Through Multiple Kernel Learning and Network Impulsive Dynamics.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Melanoma is a highly malignant skin cancer, and identifying its pathogenic genes is crucial for understanding its pathogenesis and developing treatment strategies. Network-based approaches effectively capture the synergistic interactions among genes and their products within biological systems, yet extracting functional insights from these complex networks remains challenging. Here, we propose a novel approach that combines multiple kernel learning and network impulsive dynamics (MKLNID) to predict melanoma-related pathogenic genes. Specifically, we construct similarity kernels of diseases and genes from the original disease-gene heterogeneous network and melanoma expression profiles. These kernels are integrated via multiple kernel learning to generate enhanced similarity networks for diseases and genes, respectively. Impulsive signals are then applied to specific nodes in the enhanced heterogeneous network, and the resulting dynamical response signatures are used to infer potential pathogenic genes. Comprehensive experiments and case analyses demonstrate the effectiveness of MKLNID in identifying melanoma-related genes. By deeply integrating heterogeneous disease networks with omics data and introducing network dynamics to simulate gene responses, MKLNID offers a new strategy for identifying melanoma-related genes, with potential implications for precision diagnosis and therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.